Idiopathic hemifacial spasm responsive to zonisamide: a case report

Clin Neuropharmacol. 2009 Jul-Aug;32(4):230-1. doi: 10.1097/WNF.0b013e31819a68dc.

Abstract

Aim: We describe a patient with idiopathic hemifacial spasm (HFS) that was responsive to zonisamide treatment.

Methods and results: A 65-year-old woman presented with a 4-year history of left-sided HFS developing gradually, starting from the upper facial muscles. After several analyses, the diagnosis of idiopathic HFS was made, and the clonazepam treatment (0.5 mg every 8 hours) was started, without a complete remission of symptoms. Therefore, zonisamide (150 mg twice a day for a 6-week period) was added, with a complete resolution. The rechallenge with zonisamide after its dechallenge confirmed its effectiveness. During follow-up, the patient remained symptom-free, with no adverse drug reactions.

Conclusions: We suggest that zonisamide could represent a useful therapeutic option in the treatment of idiopathic HFS.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anticonvulsants / therapeutic use*
  • Clonazepam / therapeutic use
  • Drug Therapy, Combination
  • Facial Muscles / drug effects*
  • Facial Muscles / physiopathology
  • Female
  • Hemifacial Spasm / drug therapy*
  • Hemifacial Spasm / physiopathology
  • Humans
  • Isoxazoles / therapeutic use*
  • Treatment Outcome
  • Zonisamide

Substances

  • Anticonvulsants
  • Isoxazoles
  • Zonisamide
  • Clonazepam